Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 876,615Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 40ABBVIE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 7304036

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1278

Delist Requested :

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2026-08-30

Abbvie Company Banner

02

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 9708371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1515

Delist Requested :

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2033-08-16

Abbvie Company Banner

03

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 7304036

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1278

Delist Requested :

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2026-08-30

Abbvie Company Banner

04

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 9708371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1515

Delist Requested :

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2033-08-16

Abbvie Company Banner

05

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 9708371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1516

Delist Requested :

Patent Use Description : METHOD OF TREATING CHR...

Patent Expiration Date : 2033-08-16

Abbvie Company Banner

06

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 8748573

Drug Substance Claim :

Drug Product Claim :

Application Number : 202811

Patent Use Code : U-1516

Delist Requested :

Patent Use Description : METHOD OF TREATING CHR...

Patent Expiration Date : 2031-10-30

Abbvie Company Banner

07

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 8748573

Drug Substance Claim :

Drug Product Claim :

Application Number : 202811

Patent Use Code : U-1515

Delist Requested :

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2031-10-30

Abbvie Company Banner

08

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 7304036

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1516

Delist Requested :

Patent Use Description : METHOD OF TREATING CHR...

Patent Expiration Date : 2026-08-30

Abbvie Company Banner

09

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 8110553

Drug Substance Claim :

Drug Product Claim :

Application Number : 202811

Patent Use Code : U-1278

Delist Requested :

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2024-01-28

Abbvie Company Banner

10

arrow
Antibody Engineering
Not Confirmed

LINACLOTIDE

US Patent Number : 8748573

Drug Substance Claim :

Drug Product Claim :

Application Number : 202811

Patent Use Code : U-1516

Delist Requested :

Patent Use Description : METHOD OF TREATING CHR...

Patent Expiration Date : 2031-10-30

Abbvie Company Banner